A9BMV6 AF NFT

Dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifbd6qu3srepnjytscezkz3r2salkec5zdayx3gji67khefzv7kiq/metadata.json
IPFS of structure file: 
bafybeiau2az447ey2o5cqm35ncgnprauagugh5z5f7xtgjml5mictg36ua/AF-A9BMV6-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x75B24D2B0e9632594da11Dd7fB5CA6a718195Fd6
First NFT owner address (bech32): 
genesis1wkey62cwjce9jndprhtlkh9x5uvpjh7keg6wg5
Current NFT ID #378231 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378231
Accession (UniProt):
A9BMV6
Name::
Dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
Delftia acidovorans (strain DSM 14801 / SPH-1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A9BMV6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A9BMV6|RLMN_DELAS Dual-specificity RNA methyltransferase RlmN OS=Delftia acidovorans (strain DSM 14801 / SPH-1) OX=398578 GN=rlmN PE=3 SV=2 MNTNLLDFDLDGLAAYCEQLGEKRFRATQLFRWIHQRGASDFDQMSDLAKSLREKLKACAHITALPVLTEHVSADGTVKWLFDVGGGDAVEAVFIPEDDRGTLCVSSQAGCAVGCRFCSTGHQGFSRNLSTGEILAQLWYAEHSLRKRLGTGGERVISNVVMMGMGEPLQNYTALVPALRAMLDDHGYGLSRRRVTVSTSGVVPMIDRLSQDCAVAMAVSLHAPNDELRDPLVPLNRKYPIHELLDACERYLEFAPRDFITFEYCMLDGVNDQPEHARQLIELVRARGDGRSWCKFNLIPFNPFPASGLLRSPAARVTEFASLLSNAGIVTTVRKTRGDDIDAACGQLAGDVKDRTRAAERMARQRTIVLKQVP